Voyong Fund
沃永基金
Voyong Fund (沃永基金) is a venture capital fund that co-led the over-100-million-RMB Pre-A round of PAM2L Biotechnologies (柏垠生物) in January 2023, alongside Yunqi Capital and Fuhua Capital. The deal, which also saw follow-on investment from Cornerstone Capital and Yayi Capital, was for a synthetic biology company founded in March 2021 by researchers from the Chinese Academy of Sciences. elsewhere's corpus does not contain additional information about Voyong Fund's founding, team, or broader investment strategy beyond this single transaction.
AI-generated — may contain errors, please verify.
Coverage
February: Returning to Our Imagination of the World | 5Y News Monthly
The big news from last month.
5Y News | Portfolio Company PAM2L Biotechnologies Closes Pre-A Round of Over 100 Million RMB
Leveraging synthetic biology and machine learning as dual engines to drive bio-based materials and product development.
"Bioyen Bio" Closes Over 100 Million Yuan Pre-A Round, Led by Yunqi Capital | Yunqi Capital
Leading research in materials synthetic biology, building an efficient innovation R&D platform
